Awaiting product image

Article: PP61 A randomized, double-blind, placebo-controlled, phase 3 study of caplacizumab in patients with acquired thrombotic thrombocytopenic purpura

€2.42

SKU: product-article-15356 Category:

Description

PP61 A randomized, double-blind, placebo-controlled, phase 3 study of caplacizumab in patients with acquired thrombotic thrombocytopenic purpura

Reviews

There are no reviews yet.

Be the first to review “Article: PP61 A randomized, double-blind, placebo-controlled, phase 3 study of caplacizumab in patients with acquired thrombotic thrombocytopenic purpura”

Your email address will not be published. Required fields are marked *

Related products